newsfilter
← Latest News
GlobeNewswire·

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

Strengthens position to become a leader in the intradermal delivery of FDA prescription-based ketamine products Supports commercializing novel uses and delivery methods of psychedelics TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holding